FDA Will Accept Primary Mode Of Action Definition Comments Until Jan. 24

Clarification of primary mode of action (PMOA) is a priority for the soon-to-be established Office of Combination Products, according to Mark Kramer, director of the agency's current combination product program within the FDA Office of the Ombudsman

More from Archive

More from Medtech Insight